Improving care management of pulmonary diseases and allergies through integrated, end-to-end solutions.
Respiratory conditions like asthma and COPD require consistent medication dosing. Aptar Digital Health develops solutions that empower patients to feel confident and engaged in disease management. Our end-to-end platform supports patients at every stage, from prevention to diagnosis and ongoing management. Utilizing AI-based tools and smart sensors, we improve well-being, enable accurate diagnosis, and simplify daily care. Experience Aptar Digital Health’s transformative solutions for respiratory conditions.
With Allergy Buddy, users can benefit from a proactive, user-centric mobile app designed to help them living with allergic rhinitis and seasonal allergies, to feel more prepared, supported, and in control when allergen arise. Allergy Buddy is the user’s ally that blends real-time local weather and air quality with quick, easy check-ins to deliver clear, trustworthy guidance.
Managing respiratory diseases often involves using multiple devices for diagnosis, tracking, and intervention, making data collection and analysis complicated, decentrilized and time-consuming. Our respiratory disease management platform streamlines this process, aggregating all data flows into a single, accessible smartphone app.
The platform offers a variety of unique tools for improved disease management, including adherence monitoring, lung function assessment, symptom reporting, and trigger identification. Additionally, patients have access to educational resources, training content, and direct communication channels with their care team and health coaches.
Our impact on respiratory care illustrates Aptar Digital Health’s capability to innovate within connected drug delivery systems. Beyond the mobile app solution, we have developed a connected add-on for pressurized Metered Dose Inhalers (pMDIs):
An observational study showed Aptar Digital Health’s Respiratory Disease Management Platform meaningfully improved asthma control and reduced the use of rescue medication.
Starting confidently a self-injected therapy is key to ensure adherence, engagement and better health outcomes. SureStartRx™ is a tailored digital program designed to support patients initiating self-injected therapies. Developed with our sister company Noble, an Aptar Pharma company, the program combines training and onboarding capabilities with digital education guidelines from the first dose.
Noble Sure StartRx ™ helps bridge the gap between dispensing medication and long-term adherence by supporting patients early in their treatment journey.
"*" indicates required fields
* to process your contact request. If you do not fill them in, your request cannot be processed. To find out more about the use of your personal data and how to exercise your rights, please consult the Privacy Policy
